SC
QNTM

Scotia Capital’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Scotia Capital’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-943
Closed -$43K – 882
2024
Q1 		$43K Hold
943
– – ﹤0.01% 811
2023
Q4 		$55.5K Buy
+943
New +$66.4K ﹤0.01% 775

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Scotia Capital's QNTM Position: Q2 2024 in Review

Scotia Capital sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q2 2024, closing a stake of 943 shares — an estimated $43K sold.

Scotia Capital first reported a position in QNTM in Q4 2023 and held it in 2 quarters. The position peaked at $55.5K in Q4 2023. 14 funds tracked by Wall St. Rank hold QNTM as of Q2 2024.

  • Scotia Capital reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q2 2024 after selling out during the quarter.
  • Scotia Capital sold 943 Quantum Biopharma Class B Subordinate Voting Shares shares in Q2 2024, an estimated $43K.
  • Scotia Capital first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2023 and held it in 2 quarters.
  • Scotia Capital's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $55.5K in Q4 2023.
  • 14 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2024.

Based on Scotia Capital's 13F filing for Q2 2024, filed 14 Aug 2024.